▶ 調査レポート

ヘプシジンの世界市場(~2026年)

• 英文タイトル:Global Hepcidin Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。ヘプシジンの世界市場(~2026年) / Global Hepcidin Market Insights and Forecast to 2026 / MRC2-11QY01132資料のイメージです。• レポートコード:MRC2-11QY01132
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はヘプシジンのグローバル市場について調査・分析したレポートです。種類別(DS-79182026、M-009、PRS-080、PTG-300、その他)市場規模、用途別(急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ヘプシジンの競争状況、市場シェア
・世界のヘプシジン市場:種類別市場規模 2015年-2020年(DS-79182026、M-009、PRS-080、PTG-300、その他)
・世界のヘプシジン市場:種類別市場規模予測 2021年-2026年(DS-79182026、M-009、PRS-080、PTG-300、その他)
・世界のヘプシジン市場:用途別市場規模 2015年-2020年(急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他)
・世界のヘプシジン市場:用途別市場規模予測 2021年-2026年(急性炎症、貧血、鉄欠乏性貧血、鎌状赤血球症、その他)
・北米のヘプシジン市場分析:米国、カナダ
・ヨーロッパのヘプシジン市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのヘプシジン市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のヘプシジン市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのヘプシジン市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Daiichi Sankyo Co Ltd、Pieris Pharmaceuticals Inc、Protagonist Therapeutics Inc、Noxxon Pharma AG
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Hepcidin Market
The global Hepcidin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Hepcidin Scope and Market Size
Hepcidin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hepcidin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Hepcidin market is segmented into
DS-79182026
M-009
PRS-080
PTG-300
Others

Segment by Application, the Hepcidin market is segmented into
Acute Inflammation
Anemia
Iron Deficiency Anemia
Sickle Cell Disease
Others

Regional and Country-level Analysis
The Hepcidin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Hepcidin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Hepcidin Market Share Analysis
Hepcidin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Hepcidin business, the date to enter into the Hepcidin market, Hepcidin product introduction, recent developments, etc.

The major vendors covered:
Daiichi Sankyo Co Ltd
Pieris Pharmaceuticals Inc
Protagonist Therapeutics Inc
Noxxon Pharma AG

レポート目次

1 Study Coverage
1.1 Hepcidin Product Introduction
1.2 Market Segments
1.3 Key Hepcidin Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Hepcidin Market Size Growth Rate by Type
1.4.2 DS-79182026
1.4.3 M-009
1.4.4 PRS-080
1.4.5 PTG-300
1.4.6 Others
1.5 Market by Application
1.5.1 Global Hepcidin Market Size Growth Rate by Application
1.5.2 Acute Inflammation
1.5.3 Anemia
1.5.4 Iron Deficiency Anemia
1.5.5 Sickle Cell Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Hepcidin Market Size, Estimates and Forecasts
2.1.1 Global Hepcidin Revenue 2015-2026
2.1.2 Global Hepcidin Sales 2015-2026
2.2 Global Hepcidin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Hepcidin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Hepcidin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Hepcidin Competitor Landscape by Players
3.1 Hepcidin Sales by Manufacturers
3.1.1 Hepcidin Sales by Manufacturers (2015-2020)
3.1.2 Hepcidin Sales Market Share by Manufacturers (2015-2020)
3.2 Hepcidin Revenue by Manufacturers
3.2.1 Hepcidin Revenue by Manufacturers (2015-2020)
3.2.2 Hepcidin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Hepcidin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Hepcidin Revenue in 2019
3.2.5 Global Hepcidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Hepcidin Price by Manufacturers
3.4 Hepcidin Manufacturing Base Distribution, Product Types
3.4.1 Hepcidin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Hepcidin Product Type
3.4.3 Date of International Manufacturers Enter into Hepcidin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Hepcidin Market Size by Type (2015-2020)
4.1.1 Global Hepcidin Sales by Type (2015-2020)
4.1.2 Global Hepcidin Revenue by Type (2015-2020)
4.1.3 Hepcidin Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Hepcidin Market Size Forecast by Type (2021-2026)
4.2.1 Global Hepcidin Sales Forecast by Type (2021-2026)
4.2.2 Global Hepcidin Revenue Forecast by Type (2021-2026)
4.2.3 Hepcidin Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Hepcidin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Hepcidin Market Size by Application (2015-2020)
5.1.1 Global Hepcidin Sales by Application (2015-2020)
5.1.2 Global Hepcidin Revenue by Application (2015-2020)
5.1.3 Hepcidin Price by Application (2015-2020)
5.2 Hepcidin Market Size Forecast by Application (2021-2026)
5.2.1 Global Hepcidin Sales Forecast by Application (2021-2026)
5.2.2 Global Hepcidin Revenue Forecast by Application (2021-2026)
5.2.3 Global Hepcidin Price Forecast by Application (2021-2026)

6 North America
6.1 North America Hepcidin by Country
6.1.1 North America Hepcidin Sales by Country
6.1.2 North America Hepcidin Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Hepcidin Market Facts & Figures by Type
6.3 North America Hepcidin Market Facts & Figures by Application

7 Europe
7.1 Europe Hepcidin by Country
7.1.1 Europe Hepcidin Sales by Country
7.1.2 Europe Hepcidin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Hepcidin Market Facts & Figures by Type
7.3 Europe Hepcidin Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Hepcidin by Region
8.1.1 Asia Pacific Hepcidin Sales by Region
8.1.2 Asia Pacific Hepcidin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Hepcidin Market Facts & Figures by Type
8.3 Asia Pacific Hepcidin Market Facts & Figures by Application

9 Latin America
9.1 Latin America Hepcidin by Country
9.1.1 Latin America Hepcidin Sales by Country
9.1.2 Latin America Hepcidin Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Hepcidin Market Facts & Figures by Type
9.3 Central & South America Hepcidin Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Hepcidin by Country
10.1.1 Middle East and Africa Hepcidin Sales by Country
10.1.2 Middle East and Africa Hepcidin Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Hepcidin Market Facts & Figures by Type
10.3 Middle East and Africa Hepcidin Market Facts & Figures by Application

11 Company Profiles
11.1 Daiichi Sankyo Co Ltd
11.1.1 Daiichi Sankyo Co Ltd Corporation Information
11.1.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.1.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Co Ltd Hepcidin Products Offered
11.1.5 Daiichi Sankyo Co Ltd Related Developments
11.2 Pieris Pharmaceuticals Inc
11.2.1 Pieris Pharmaceuticals Inc Corporation Information
11.2.2 Pieris Pharmaceuticals Inc Description and Business Overview
11.2.3 Pieris Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pieris Pharmaceuticals Inc Hepcidin Products Offered
11.2.5 Pieris Pharmaceuticals Inc Related Developments
11.3 Protagonist Therapeutics Inc
11.3.1 Protagonist Therapeutics Inc Corporation Information
11.3.2 Protagonist Therapeutics Inc Description and Business Overview
11.3.3 Protagonist Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Protagonist Therapeutics Inc Hepcidin Products Offered
11.3.5 Protagonist Therapeutics Inc Related Developments
11.4 Noxxon Pharma AG
11.4.1 Noxxon Pharma AG Corporation Information
11.4.2 Noxxon Pharma AG Description and Business Overview
11.4.3 Noxxon Pharma AG Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Noxxon Pharma AG Hepcidin Products Offered
11.4.5 Noxxon Pharma AG Related Developments
11.1 Daiichi Sankyo Co Ltd
11.1.1 Daiichi Sankyo Co Ltd Corporation Information
11.1.2 Daiichi Sankyo Co Ltd Description and Business Overview
11.1.3 Daiichi Sankyo Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Co Ltd Hepcidin Products Offered
11.1.5 Daiichi Sankyo Co Ltd Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Hepcidin Market Estimates and Projections by Region
12.1.1 Global Hepcidin Sales Forecast by Regions 2021-2026
12.1.2 Global Hepcidin Revenue Forecast by Regions 2021-2026
12.2 North America Hepcidin Market Size Forecast (2021-2026)
12.2.1 North America: Hepcidin Sales Forecast (2021-2026)
12.2.2 North America: Hepcidin Revenue Forecast (2021-2026)
12.2.3 North America: Hepcidin Market Size Forecast by Country (2021-2026)
12.3 Europe Hepcidin Market Size Forecast (2021-2026)
12.3.1 Europe: Hepcidin Sales Forecast (2021-2026)
12.3.2 Europe: Hepcidin Revenue Forecast (2021-2026)
12.3.3 Europe: Hepcidin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Hepcidin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Hepcidin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Hepcidin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Hepcidin Market Size Forecast by Region (2021-2026)
12.5 Latin America Hepcidin Market Size Forecast (2021-2026)
12.5.1 Latin America: Hepcidin Sales Forecast (2021-2026)
12.5.2 Latin America: Hepcidin Revenue Forecast (2021-2026)
12.5.3 Latin America: Hepcidin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Hepcidin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Hepcidin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Hepcidin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Hepcidin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Hepcidin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Hepcidin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Hepcidin Market Segments
Table 2. Ranking of Global Top Hepcidin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Hepcidin Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of DS-79182026
Table 5. Major Manufacturers of M-009
Table 6. Major Manufacturers of PRS-080
Table 7. Major Manufacturers of PTG-300
Table 8. Major Manufacturers of Others
Table 9. Global Hepcidin Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Hepcidin Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Hepcidin Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Hepcidin Sales Market Share by Regions (2015-2020)
Table 13. Global Hepcidin Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Hepcidin Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Hepcidin Sales Share by Manufacturers (2015-2020)
Table 16. Global Hepcidin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Hepcidin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepcidin as of 2019)
Table 18. Hepcidin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Hepcidin Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Hepcidin Price (2015-2020) (USD/Pcs)
Table 21. Hepcidin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Hepcidin Product Type
Table 23. Date of International Manufacturers Enter into Hepcidin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 26. Global Hepcidin Sales Share by Type (2015-2020)
Table 27. Global Hepcidin Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Hepcidin Revenue Share by Type (2015-2020)
Table 29. Hepcidin Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 31. Global Hepcidin Sales Share by Application (2015-2020)
Table 32. North America Hepcidin Sales by Country (2015-2020) (K Pcs)
Table 33. North America Hepcidin Sales Market Share by Country (2015-2020)
Table 34. North America Hepcidin Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Hepcidin Revenue Market Share by Country (2015-2020)
Table 36. North America Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 37. North America Hepcidin Sales Market Share by Type (2015-2020)
Table 38. North America Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 39. North America Hepcidin Sales Market Share by Application (2015-2020)
Table 40. Europe Hepcidin Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Hepcidin Sales Market Share by Country (2015-2020)
Table 42. Europe Hepcidin Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Hepcidin Revenue Market Share by Country (2015-2020)
Table 44. Europe Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Hepcidin Sales Market Share by Type (2015-2020)
Table 46. Europe Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Hepcidin Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Hepcidin Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Hepcidin Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Hepcidin Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Hepcidin Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Hepcidin Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Hepcidin Sales Market Share by Application (2015-2020)
Table 56. Latin America Hepcidin Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Hepcidin Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Hepcidin Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Hepcidin Revenue Market Share by Country (2015-2020)
Table 60. Latin America Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Hepcidin Sales Market Share by Type (2015-2020)
Table 62. Latin America Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Hepcidin Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Hepcidin Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Hepcidin Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Hepcidin Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Hepcidin Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Hepcidin Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Hepcidin Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Hepcidin Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Hepcidin Sales Market Share by Application (2015-2020)
Table 72. Daiichi Sankyo Co Ltd Corporation Information
Table 73. Daiichi Sankyo Co Ltd Description and Major Businesses
Table 74. Daiichi Sankyo Co Ltd Hepcidin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Daiichi Sankyo Co Ltd Product
Table 76. Daiichi Sankyo Co Ltd Recent Development
Table 77. Pieris Pharmaceuticals Inc Corporation Information
Table 78. Pieris Pharmaceuticals Inc Description and Major Businesses
Table 79. Pieris Pharmaceuticals Inc Hepcidin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Pieris Pharmaceuticals Inc Product
Table 81. Pieris Pharmaceuticals Inc Recent Development
Table 82. Protagonist Therapeutics Inc Corporation Information
Table 83. Protagonist Therapeutics Inc Description and Major Businesses
Table 84. Protagonist Therapeutics Inc Hepcidin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Protagonist Therapeutics Inc Product
Table 86. Protagonist Therapeutics Inc Recent Development
Table 87. Noxxon Pharma AG Corporation Information
Table 88. Noxxon Pharma AG Description and Major Businesses
Table 89. Noxxon Pharma AG Hepcidin Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Noxxon Pharma AG Product
Table 91. Noxxon Pharma AG Recent Development
Table 92. Global Hepcidin Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Hepcidin Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Hepcidin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Hepcidin Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Hepcidin Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Hepcidin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Hepcidin Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Hepcidin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Hepcidin Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Hepcidin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Hepcidin Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Hepcidin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Hepcidin Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Hepcidin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Hepcidin Players
Table 110. Hepcidin Customers List
Table 111. Hepcidin Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Hepcidin Product Picture
Figure 2. Global Hepcidin Sales Market Share by Type in 2020 & 2026
Figure 3. DS-79182026 Product Picture
Figure 4. M-009 Product Picture
Figure 5. PRS-080 Product Picture
Figure 6. PTG-300 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Hepcidin Sales Market Share by Application in 2020 & 2026
Figure 9. Acute Inflammation
Figure 10. Anemia
Figure 11. Iron Deficiency Anemia
Figure 12. Sickle Cell Disease
Figure 13. Others
Figure 14. Hepcidin Report Years Considered
Figure 15. Global Hepcidin Market Size 2015-2026 (US$ Million)
Figure 16. Global Hepcidin Sales 2015-2026 (K Pcs)
Figure 17. Global Hepcidin Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Hepcidin Sales Market Share by Region (2015-2020)
Figure 19. Global Hepcidin Sales Market Share by Region in 2019
Figure 20. Global Hepcidin Revenue Market Share by Region (2015-2020)
Figure 21. Global Hepcidin Revenue Market Share by Region in 2019
Figure 22. Global Hepcidin Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Hepcidin Revenue in 2019
Figure 24. Hepcidin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Hepcidin Sales Market Share by Type (2015-2020)
Figure 26. Global Hepcidin Sales Market Share by Type in 2019
Figure 27. Global Hepcidin Revenue Market Share by Type (2015-2020)
Figure 28. Global Hepcidin Revenue Market Share by Type in 2019
Figure 29. Global Hepcidin Market Share by Price Range (2015-2020)
Figure 30. Global Hepcidin Sales Market Share by Application (2015-2020)
Figure 31. Global Hepcidin Sales Market Share by Application in 2019
Figure 32. Global Hepcidin Revenue Market Share by Application (2015-2020)
Figure 33. Global Hepcidin Revenue Market Share by Application in 2019
Figure 34. North America Hepcidin Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Hepcidin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Hepcidin Sales Market Share by Country in 2019
Figure 37. North America Hepcidin Revenue Market Share by Country in 2019
Figure 38. U.S. Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Hepcidin Market Share by Type in 2019
Figure 43. North America Hepcidin Market Share by Application in 2019
Figure 44. Europe Hepcidin Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Hepcidin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Hepcidin Sales Market Share by Country in 2019
Figure 47. Europe Hepcidin Revenue Market Share by Country in 2019
Figure 48. Germany Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Hepcidin Market Share by Type in 2019
Figure 59. Europe Hepcidin Market Share by Application in 2019
Figure 60. Asia Pacific Hepcidin Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Hepcidin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Hepcidin Sales Market Share by Region in 2019
Figure 63. Asia Pacific Hepcidin Revenue Market Share by Region in 2019
Figure 64. China Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Hepcidin Market Share by Type in 2019
Figure 87. Asia Pacific Hepcidin Market Share by Application in 2019
Figure 88. Latin America Hepcidin Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Hepcidin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Hepcidin Sales Market Share by Country in 2019
Figure 91. Latin America Hepcidin Revenue Market Share by Country in 2019
Figure 92. Mexico Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Hepcidin Market Share by Type in 2019
Figure 99. Latin America Hepcidin Market Share by Application in 2019
Figure 100. Middle East and Africa Hepcidin Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Hepcidin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Hepcidin Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Hepcidin Revenue Market Share by Country in 2019
Figure 104. Turkey Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Hepcidin Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Hepcidin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Hepcidin Market Share by Type in 2019
Figure 111. Middle East and Africa Hepcidin Market Share by Application in 2019
Figure 112. North America Hepcidin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Hepcidin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Hepcidin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Hepcidin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Hepcidin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Hepcidin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Hepcidin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Hepcidin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Hepcidin Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Hepcidin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed